170 related articles for article (PubMed ID: 12381969)
1. Beta interferons for multiple sclerosis.
Med Lett Drugs Ther; 2002 Oct; 44(1141):88-9. PubMed ID: 12381969
[No Abstract] [Full Text] [Related]
2. Use of interferon-beta in the treatment of multiple sclerosis.
Derwenskus J; Lublin FD
Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838
[No Abstract] [Full Text] [Related]
3. Interferon beta-1B for multiple sclerosis.
Med Lett Drugs Ther; 1993 Jul; 35(900):61-2. PubMed ID: 8515719
[No Abstract] [Full Text] [Related]
4. Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis.
Banwell B; Tremlett H
Neurology; 2005 Mar; 64(5):778-9. PubMed ID: 15753408
[No Abstract] [Full Text] [Related]
5. Lessons from randomised direct comparative trials.
Achiron A; Fredrikson S
J Neurol Sci; 2009 Feb; 277 Suppl 1():S19-24. PubMed ID: 19200860
[TBL] [Abstract][Full Text] [Related]
6. Interferon neutralizing antibodies in multiple sclerosis: a new perspective.
Phillips JT
Arch Neurol; 2010 Apr; 67(4):386-7. PubMed ID: 20385901
[No Abstract] [Full Text] [Related]
7. Interferon beta: the current position.
Boothman BR
Br J Hosp Med; 1997 Mar 19-Apr 1; 57(6):277-80. PubMed ID: 9196574
[TBL] [Abstract][Full Text] [Related]
8. ["The largest snapshot of multiple sclerosis". Interferons compared].
MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866307
[No Abstract] [Full Text] [Related]
9. Interferon beta and multiple sclerosis: look at the evidence.
Patti F; Reggio A
Int J Clin Pract Suppl; 2002 Sep; (131):23-32. PubMed ID: 12564809
[TBL] [Abstract][Full Text] [Related]
10. Once weekly interferon beta for multiple sclerosis is superseded by higher and more frequent dosing.
Blumhardt LD
Int J Clin Pract Suppl; 2002 Sep; (131):9-16. PubMed ID: 12564807
[TBL] [Abstract][Full Text] [Related]
11. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.
Gout O
Ann Neurol; 2008 Jan; 63(1):126; author reply 126-7. PubMed ID: 17702028
[No Abstract] [Full Text] [Related]
12. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
Schwid SR; Panitch HS
Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
[TBL] [Abstract][Full Text] [Related]
13. [Interferon-beta treatment of progressive disseminated sclerosis. Is it possibly without effect?].
Foldspang A
Ugeskr Laeger; 1999 Aug; 161(31):4418-21. PubMed ID: 10487112
[No Abstract] [Full Text] [Related]
14. Interferon beta-1A for relapsing multiple sclerosis.
Med Lett Drugs Ther; 1996 Jul; 38(979):63-4. PubMed ID: 8692073
[No Abstract] [Full Text] [Related]
15. Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a.
Pakdaman H; Fallah A; Sahraian MA; Pakdaman R; Meysamie A
Neuropediatrics; 2006 Aug; 37(4):257-60. PubMed ID: 17177154
[TBL] [Abstract][Full Text] [Related]
16. [10 years of interferon treatment in multiple sclerosis. Does the future belong to high-dose therapy?].
MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579501
[No Abstract] [Full Text] [Related]
17. Interferon-beta therapy for MS: the dilemma of having choices.
Khan O
J Neurol Sci; 2004 Jul; 222(1-2):1. PubMed ID: 15240187
[No Abstract] [Full Text] [Related]
18. Advancing treatment with interferon beta-1b (Betaferon/Betaseron) in the next decade--thinking beyond the standard dose.
Cook SD
J Neurol; 2003 Dec; 250 Suppl 4():IV15-20. PubMed ID: 14712397
[TBL] [Abstract][Full Text] [Related]
19. Interferons and cognition.
Montalban X; Rio J
J Neurol Sci; 2006 Jun; 245(1-2):137-40. PubMed ID: 16626757
[TBL] [Abstract][Full Text] [Related]
20. Liver injury associated with the beta-interferons for MS.
Wallack EM; Callon R
Neurology; 2004 Sep; 63(6):1142-3; author reply 1142-3. PubMed ID: 15452330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
